{
  "slug": "invitae",
  "name": "Invitae",
  "description": "Invitae is a medical genetics company that provides comprehensive genetic testing and interpretation services. It focuses on oncology, reproductive health, and rare disease diagnostics with the goal of making genetic information accessible at scale. Following a 2024 bankruptcy filing, its assets were acquired by LabCorp.",
  "url": "https://optimly.ai/brand/invitae",
  "logoUrl": "",
  "baiScore": 78,
  "archetype": "Challenger",
  "category": "Biotechnology / Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [
    {
      "slug": "color-health",
      "name": "Color Health"
    },
    {
      "slug": "labcorp",
      "name": "Labcorp"
    },
    {
      "slug": "myriad-genetics",
      "name": "Myriad Genetics, Inc."
    },
    {
      "slug": "natera",
      "name": "Natera"
    }
  ],
  "inboundCompetitors": [
    {
      "slug": "23andme-health-ancestry-service",
      "name": "23andMe Health + Ancestry Service"
    },
    {
      "slug": "23andme",
      "name": "23andMe Holding Co."
    },
    {
      "slug": "pgrx-formerly-pgx",
      "name": "Pgrx Formerly Pgx"
    },
    {
      "slug": "ancestryhealth",
      "name": "AncestryHealth"
    },
    {
      "slug": "23andme-health-village",
      "name": "23andMe Health Village"
    },
    {
      "slug": "ambry-genetics-tempus",
      "name": "Ambry Genetics"
    },
    {
      "slug": "ancestryhealth-discontinued-helix",
      "name": "Ancestryhealth Discontinued Helix"
    },
    {
      "slug": "dante-labs",
      "name": "Dante Labs"
    },
    {
      "slug": "ambry-genetics",
      "name": "Ambry Genetics"
    },
    {
      "slug": "genedx",
      "name": "GeneDx"
    },
    {
      "slug": "nebula-genomics",
      "name": "Nebula Genomics"
    },
    {
      "slug": "ancestrydna-health",
      "name": "Ancestrydna Health"
    },
    {
      "slug": "labcorp-integrated-genetics",
      "name": "Integrated Genetics"
    },
    {
      "slug": "clinical-genetic-testing",
      "name": "Clinical Genetic Testing"
    }
  ],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-04-10T06:25:10.447+00:00",
  "verifiedVitals": {
    "website": "https://www.invitae.com",
    "founded": "2010",
    "headquarters": "San Francisco, California, USA",
    "pricing_model": "Insurance-based, Patient-Pay (Fixed-price), and Institutional Billing.",
    "core_products": "Hereditary Cancer Panels, Reproductive Health (NIPS/Carrier) Testing, Rare Disease Diagnostics, Pharmacogenomics Panels.",
    "key_differentiator": "A mission-driven focus on reducing the cost of genetic testing to democratize access to genomic data for all patients.",
    "target_markets": "Physicians, Health Systems, Genetic Counselors, and Patients.",
    "employee_count": "1,000-5,000 (pre-acquisition)",
    "funding_stage": "Acquired (Post-Bankruptcy)",
    "subcategory": "Genetic Diagnostics & Personalized Medicine"
  },
  "intentTags": {
    "problemIntents": [
      "In-house Hospital Labs: Hospitals often use internal genetics departments or academic medical centers for testing and interpretation.",
      "Genetic Counseling AgenciesCare Management: Specialized genetic counseling firms that manage the testing process via various third-party labs for patients."
    ],
    "solutionIntents": [
      "hereditary cancer genetic testing companies",
      "affordable whole genome sequencing for patients",
      "best carrier screening for pregnancy 2024",
      "genetic testing for rare diseases",
      "is invitae still in business",
      "Standard Diagnostic Imaging/Pathology: Using general oncology or prenatal diagnostic tools that don't include comprehensive genetic sequencing."
    ],
    "evaluationIntents": []
  },
  "timestamp": 1777197754791
}